Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 70/100

Failure Rate

33.3%

1 terminated/withdrawn out of 3 trials

Success Rate

66.7%

-19.9% vs industry average

Late-Stage Pipeline

67%

2 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed trials have results

Key Signals

Enrollment Performance

Analytics

Phase 4
2(100.0%)
2Total
Phase 4(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (3)

Showing 3 of 3 trials
NCT01817699Phase 4Terminated

Correcting Anemia and Native Vitamin D Supplementation in Kidney Transplant Recipients

Role: collaborator

NCT02214563Phase 4Completed

Cholecalciferol Supplementation for Anemia and Mineral and Bone Disorder in Hemodialysis Patients

Role: collaborator

NCT01855087Completed

Safety and Efficacy of Sitagliptin Added to Insulin Therapy for Type 2 Diabetes

Role: collaborator

All 3 trials loaded